UB Paderborn / Katalog / Suche / in CDI

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-12, Vol.31 (34), p.4349-4357

2013

Volltextzugriff (PDF)

Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099

Journal of clinical oncology, 2010-02, Vol.28 (6), p.911-917

2010

Volltextzugriff (PDF)

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-02, Vol.28 (6), p.918-927

2010

Volltextzugriff (PDF)

Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4394-4400

2011

Volltextzugriff (PDF)

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1746-1751

2003

Volltextzugriff (PDF)

A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Clinical cancer research, 2013, Vol.19 (1), p.258-267

2013

Volltextzugriff (PDF)

Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2―Negative Advanced Breast Cancer That Progressed during or after Bevacizumab

Clinical cancer research, 2013-05, Vol.19 (10), p.2745-2754

2013

Volltextzugriff (PDF)

Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2015-02, Vol.10 (2), p.353-359

2015

Volltextzugriff (PDF)

Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non–Small-Cell Lung Cancer

Clinical lung cancer, 2015-05, Vol.16 (3), p.200-208

2015

Volltextzugriff (PDF)

Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G2

JNCI : Journal of the National Cancer Institute, 2004-10, Vol.96 (20), p.1557-1559

2004

Volltextzugriff (PDF)

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

The New England journal of medicine, 2014-07, Vol.371 (3), p.213-223

2014

Volltextzugriff (PDF)

Neurological manifestations of Erdheim-Chester disease

Journal of neurology, neurosurgery and psychiatry, 1999-01, Vol.66 (1), p.72-75

1999

Volltextzugriff (PDF)

Development of a multidisciplinary program for evaluation and treatment of pancreatic cancer in a community healthcare system

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.303-303

2016

Volltextzugriff (PDF)

Phase I/II study of neoadjuvant eribulin mesylate, carboplatin, and trastuzumab (ECH) for operable HER2 positive (HER2+) breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.604-604

2014

Volltextzugriff (PDF)

Phase I/II study of neoadjuvant carboplatin, eribulin mesylate, and trastuzumab (ECH) for operable HER2 positive (HER2+) breast cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS659-TPS659

2013

Volltextzugriff (PDF)

PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7551-7551

2015

Volltextzugriff (PDF)

Exploratory analyses of efficacy and safety of pemetrexed (Pem) plus bevacizumab (Bev) and bev alone as maintenance therapy (MT) in patients (Pts) with stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8012-8012

2013

Volltextzugriff (PDF)

Randomized phase III trial of pemetrexed (Pem)+carboplatin (Cb)+bevacizumab (Bev) followed by maintenance Pem+Bev (Pem arm) versus paclitaxel (Pac)+Cb+Bev followed by maintenance Bev (Pac arm) in patients (pts) with stage IIIb/IV nonsquamous non-small cell lung cancer (nsNSCLC) (POINTBREAK): African American (AA) subset

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e19150-e19150

2013

Volltextzugriff (PDF)

Translational research (TR) results from pointbreak: A randomized, open-label, phase III study of pemetrexed (Pem)+carboplatin (Cb)+bevacizumab (Bev) followed by maintenance pem+bev (Pem Arm) versus paclitaxel (Pac)+cb+bev followed by maintenance bev (Pac Arm) in patients (pts) with stage IIIB or IV nonsquamous non-small cell lung cancer (ns-NSCLC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8086-8086

2013

Volltextzugriff (PDF)

Human papillomavirus (HPV)-associated early stage non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.7560-7560

2013

Volltextzugriff (PDF)

Patient-reported outcomes from POINTBREAK: The randomized, open-label, phase III study of pemetrexed (pem) + carboplatin (cb) + bevacizumab (bev) followed by maintenance pem + bev versus paclitaxel (pac) + cb + bev followed by maintenance bev in patients with stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC)

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.53-53

2012

Volltextzugriff (PDF)

Neurologic complications after total shoulder arthroplasty

Journal of shoulder and elbow surgery, 1996, Vol.5 (1), p.53-61

1996

Volltextzugriff (PDF)

Electrophysiologic findings in amyloid myopathy

Muscle & nerve, 1999-03, Vol.22 (3), p.355-359

1999

Volltextzugriff (PDF)

Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G sub(2)

JNCI : Journal of the National Cancer Institute, 2004-10, Vol.96 (20), p.1557-1559

2004

Volltextzugriff (PDF)

Neurologic complications of hairy cell leukemia

Archives of neurology (Chicago), 1984-02, Vol.41 (2), p.202

1984

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer

Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2―Negative Advanced Breast Cancer That Progressed during or after Bevacizumab

Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G2

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

Neurological manifestations of Erdheim-Chester disease

Development of a multidisciplinary program for evaluation and treatment of pancreatic cancer in a community healthcare system

Phase I/II study of neoadjuvant eribulin mesylate, carboplatin, and trastuzumab (ECH) for operable HER2 positive (HER2+) breast cancer

Phase I/II study of neoadjuvant carboplatin, eribulin mesylate, and trastuzumab (ECH) for operable HER2 positive (HER2+) breast cancer

PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer

Exploratory analyses of efficacy and safety of pemetrexed (Pem) plus bevacizumab (Bev) and bev alone as maintenance therapy (MT) in patients (Pts) with stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC)

Human papillomavirus (HPV)-associated early stage non-small cell lung cancer (NSCLC)

Neurologic complications after total shoulder arthroplasty

Electrophysiologic findings in amyloid myopathy

Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G sub(2)

Neurologic complications of hairy cell leukemia

Suchergebnisse filtern